生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | 5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits various carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK), and exhibits antitumor activity. It can also trigger apoptosis[1][2][3][4][5][6][7]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.13mL 0.63mL 0.31mL |
15.67mL 3.13mL 1.57mL |
31.33mL 6.27mL 3.13mL |
参考文献 |
---|